It has been described that cancer associated with metastasis disease like breast cancer may rely on downregulation of CXCL12 to advance to ectopic sources, as they may be more susceptible to chemoattraction when turned off (Wendt et al. 2008; Yu et al. 2017). This evidence concerns the gene CXCL12 and breast cancer.